Edit |   |
Antigenic Specificity | GALNT13 (Center), 252-281 |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human, mouse (predicted reactivity: bovine, porcine, rat) |
Isotype | n/a |
Format | peptide affinity purified |
Size | 0.08 mL, 0.4 mL |
Concentration | vial concentration: 0.5 |
Applications | Western Blot (WB), ELISA (EIA) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This GALNT13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 252-281 amino acids from the Central region of human GALNT13. The GALNT13 protein is a member of theUDP-N-acetyl-alpha-D-galactosamine:polypeptideN-acetylgalactosaminyltransferase (GalNAcT; EC 2.4.1.41) family,which initiate O-linked glycosylation of mucins (see MUC3A, MIM158371) by the initial transfer of N-acetylgalactosamine (GalNAc)with an alpha-linkage to a serine or threonine residue.[supplied byOMIM]. |
Immunogen | n/a |
Other Names | [Polypeptide N-acetylgalactosaminyltransferase 13; Polypeptide GalNAc transferase 13; GalNAc-T13; pp-GaNTase 13; Protein-UDP acetylgalactosaminyltransferase 13; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13; GALNT13; KIAA1918] |
Gene, Accession # | [GALNT13], Gene ID: 114805, NCBI: NP_443149.2, UniProt: Q8IUC8 |
Catalog # | MBS9202631 |
Price | $165, $370 |
Order / More Info | GALNT13 (Center), 252-281 Antibody from MYBIOSOURCE INC. |
Product Specific References | Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Ng, D., et al. Int. J. Cancer 123(7):1610-1615(2008) Lunetta, K.L., et al. BMC Med. Genet. 8 SUPPL 1, S13 (2007) : Hillier, L.W., et al. Nature 434(7034):724-731(2005) Lehner, B., et al. Genome Res. 14(7):1315-1323(2004) |